From the editor: an exciting year ahead
Chris Arden, Editor-in-chief of the Primary Care Cardiovascular Journal
With New Year fading into the distance and the days getting longer, our attention focuses on what this year will bring in cardiovascular disease and diabetes.
We are fortunate to have a wealth of excellent evidence and guidance to inform prevention and management in this therapeutic area but there is no room for complacency as new evidence is constantly coming to light to help redefine best practice.
An increasingly important area and focus of our role in primary care is to try and prevent individuals developing cardiovascular disease and diabetes in the first place. We all recognise the significant benefits of these interventions, primarily to the individual, but also to the wider health economy. Our recently published special edition Cardiovascular Disease Prevention: Improving Outcomes in Primary Care [insert PCCJ hyperlink here – it doesn’t look as if the issue is online yet] highlights the benefits of early intervention, including practical recommendations on how to implement these in practice.
This year also sees the publication or review of several important national guidelines. NICE guidelines due for review include the Cardiovascular disease: risk assessment and reduction, including lipid modification guideline (CG181) and Cardiovascular disease prevention guidelines (PH25). The much-anticipated Hypertension in adults: diagnosis and management (CG127) guidance is in development this year, with publication planned for next summer. Meanwhile, the Chronic heart failure in adults: diagnosis and management guideline (CG108) is being updated and is due to be published in August 2018. This will be an important document and point of discussion later this year.
In the meantime, the recent American ACC/AHA High Blood Pressure Guidelines advocate tighter blood pressure control targets, although this has generated significant debate as to the feasibility, and merits, of applying these in clinical practice, especially in our more frail, elderly patients. Watch this space, and the PCCJ, to follow the debate! The European Society of Cardiology also has excellent, practical guidelines on Valvular Heart Disease and Peripheral Arterial Diseases which are well worth a read.
The highlight of the year will once again be the BJPCN/PCCJ Annual Conference Issues & Answers in Cardiovascular Disease (16-17 November 2018, EMCC Nottingham) where the theme will be ‘What’s new in cardiovascular disease and how can we do better?’ The conference will highlight all the important and topical issues in relation to improving our approach to managing cardiovascular disease and diabetes, with opportunities to discuss and share best practice. Please do join us all in Nottingham, look forward to seeing you there…!
The PCCJ will keep playing an important role in identifying, summarising and publishing the key articles and guidelines in primary care. This will continue to be supported by the Journal’s online CPD modules and clinical cards, which are an excellent resource to refer to and share with colleagues. Please also follow the Journal on Facebook (@pccjonline) and Twitter (@PCCJplus) to receive regular news and updates.